“The clinical value of ProFound AI Risk is unparalleled, and this exciting research adds to the growing body of evidence that confirms iCAD’s technology is not only more personalized than traditional ...
TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...
ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025 NASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ...
NASHUA, N.H., July 15, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced ProFound AI™ ...
NASHUA, N.H., April 20, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc (ICAD). (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new ...
This transformation is precisely why the AI for Good Global Summit is more vital today than at any point since its creation.
"While that'll continue, we are starting to run out of human-generated data being publicly available on the internet, ...
Strategic alliance combines iQuanti's data-driven marketing expertise with Profound's AI visibility intelligence to help brands capitalize on the AI Search revolution The partnership integrates ...
The MarketWatch News Department was not involved in the creation of this content. Strategic alliance combines iQuanti's data-driven marketing expertise with Profound's AI visibility intelligence to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback